Abstract
Numerous clinical trials demonstrated that the optimal log-term treatment of pelvic pain caused by endometriosis may involve the use of GnRH ana- logues (GnRH-a) to suppress ovarian estrogen production combined with add- back low doses of estrogen plus progestin or progestin only. Estrogen, as a solitary add back, is less effective and thus is not indicated. Tibolone can be used as add back therapy to prevent hypoestrogenic symptoms. Recently, the post-operative administration of GnRH-a and anastrozole have been suggested to increase the pain-free interval and decrease symptom recurrence rates in patients following surgery for severe endometriosis.
Original language | English |
---|---|
Pages | 15-18 |
Number of pages | 4 |
Publication status | Published - 1 Jan 2006 |
Event | The world meeting on gynecological pelvic pain and endometriosis - Milan Duration: 1 Jan 2006 → … |
Conference
Conference | The world meeting on gynecological pelvic pain and endometriosis |
---|---|
City | Milan |
Period | 1/01/06 → … |
Keywords
- Endometriosis
- gnrh analogue
- hormonal therapy